Neomycin B-cyclen conjugates and their Zn(II) complexes as RNA-binding agents

Journal of Inorganic Biochemistry
Bopha KongLeone Spiccia

Abstract

Three new conjugates featuring the aminoglycoside antibiotic neomycin B linked to the 1,4,7,10-tetraazacyclododecane (cyclen) macrocycle via alkyl chains of varying lengths were synthesized from suitably protected derivatives of these precursors via conventional peptide coupling protocols. The final products were characterized by1H NMR spectroscopy, mass spectrometry, and elemental analysis. FRET-based measurements examining the ability of the compounds to displace coumarin-labelled kanamycin A or neomycin B from Dy547-labelled prokaryotic ribosomal A-site RNA revealed that they bind to the A-site with slightly higher affinities than the parent aminoglycoside (e.g., IC50at pH7=1.42-2.30μM vs. 2.35μM for neomycin B). This is attributed to the higher overall positive charge of the conjugates, resulting from protonation of the macrocylic amines. Consistent with a predominantly electrostatic mode of interaction, the binding affinities of the conjugates were found to increase with decreasing pH, reflecting a greater degree of protonation at lower pH. The zinc(II) complexes of the neomycin B-cyclen conjugates were found to bind to A-site RNA with even higher affinities (IC50=0.85-1.32μM), due to the Zn(II)-cyclen motif forming coordi...Continue Reading

References

Oct 3, 2003·Chembiochem : a European Journal of Chemical Biology·Yitzhak Tor
Aug 18, 2006·Chembiochem : a European Journal of Chemical Biology·Kenneth F Blount, Yitzhak Tor
Apr 24, 2008·Tetrahedron·Seergazhi G Srivatsan, Yitzhak Tor
Dec 17, 2008·Organic & Biomolecular Chemistry·Matthew J BelousoffYitzhak Tor
Oct 6, 2009·Current Drug Targets·R MavigliaM Pennisi
Apr 17, 2010·Chembiochem : a European Journal of Chemical Biology·Jacob L HoughtonSylvie Garneau-Tsodikova
Jul 31, 2010·Expert Opinion on Therapeutic Patents·Paola Dozzo, Heinz E Moser
Oct 7, 2011·Expert Review of Anti-infective Therapy·Matteo BassettiDaniele Roberto Giacobbe
May 29, 2012·ChemMedChem·Richard J FairYitzhak Tor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.